David Demartini - Net Worth and Insider Trading
David Demartini Net Worth
The estimated net worth of David Demartini is at least $134,932 dollars as of 2024-11-13. David Demartini is the Director of Lexaria Bioscience Corp and owns about 58,666 shares of Lexaria Bioscience Corp (LEXX) stock worth over $134,932. Details can be seen in David Demartini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Demartini has not made any transactions after 2010-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Demartini
David Demartini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Demartini owns 1 companies in total, including Lexaria Bioscience Corp (LEXX) .
Click here to see the complete history of David Demartini’s form 4 insider trades.
Insider Ownership Summary of David Demartini
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2010-08-30 | director & 10 percent owner |
David Demartini Latest Holdings Summary
David Demartini currently owns a total of 1 stock. David Demartini owns 58,666 shares of Lexaria Bioscience Corp (LEXX) as of August 30, 2010, with a value of $134,932.
Latest Holdings of David Demartini
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2010-08-30 | 58,666 | 2.30 | 134,932 |
Holding Weightings of David Demartini
David Demartini Form 4 Trading Tracker
According to the SEC Form 4 filings, David Demartini has made a total of 0 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 917 shares on August 30, 2010, which cost David Demartini around $4,500.
Insider Trading History of David Demartini
- 1
David Demartini Trading Performance
GuruFocus tracks the stock performance after each of David Demartini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Demartini is 22.22%. GuruFocus also compares David Demartini's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Demartini within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Demartini's insider trading performs compared to the benchmark.
Performance of David Demartini
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 47.22 | | | | | |
| Relative Return to S&P 500(%) | 38.42 | | | | | |
David Demartini Ownership Network
Ownership Network List of David Demartini
Ownership Network Relation of David Demartini
David Demartini Owned Company Details
What does Lexaria Bioscience Corp do?
Who are the key executives at Lexaria Bioscience Corp?
David Demartini is the director & 10 percent owner of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Secretary Vanessa Carle , Chief Financial Officer Gregory Downey , and director & 10 percent owner & CEO Christopher Bunka .
Lexaria Bioscience Corp (LEXX) Insider Trades Summary
Over the past 18 months, David Demartini made no insider transaction in Lexaria Bioscience Corp (LEXX). Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net sale of 2,567 shares made by Vanessa Carle , and a net purchase of 1,600 shares made by Catherine C. Turkel .
In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,567 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,600 shares were bought by its insiders, resulting in a net sale of 967 shares.
Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexaria Bioscience Corp Insider Transactions
David Demartini Mailing Address
Above is the net worth, insider trading, and ownership report for David Demartini. You might contact David Demartini via mailing address: 11714 Spriggs Way, Houston Tx 77024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
